Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
27.28
-1.81 (-6.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
Q32 Bio Employees
Q32 Bio had 37 employees as of December 31, 2023.
Employees
37
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,638,135
Market Cap
332.29M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 37 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Enhabit | 10,800 |
| ZimVie | 2,600 |
| Ginkgo Bioworks Holdings | 1,218 |
| Amylyx Pharmaceuticals | 384 |
| Kamada | 378 |
| Omeros | 198 |
| Codexis | 174 |
| MaxCyte | 143 |
QTTB News
- 14 days ago - Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 16 days ago - Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - PRNewsWire
- 5 weeks ago - Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - PRNewsWire
- 3 months ago - Q32 Bio to Participate in Upcoming September Investor Conferences - PRNewsWire
- 3 months ago - Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 - Seeking Alpha
- 3 months ago - 8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803% - Benzinga
- 4 months ago - Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis - PRNewsWire
- 5 months ago - Q32 Bio Joins Russell 3000® Index - PRNewsWire